icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2013: 7th IAS Conference on HIV
Pathogenesis Treatment and Prevention
June 30 - July 3 2013
Kuala Lumpur, Malaysia
Back grey_arrow_rt.gif
 
 
 
Intelence and prezista Once A Day Study (INROADS): A Multicenter, Single-Arm, Open-Label Study of Once Daily Combination of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) as Dual Therapy in Early Treatment-Experienced Subjects
 
 
  Reported by Jules Levin
IAS 2013 June 30-July 3 Kuala Lumpur
 
Peter Ruane,1 Cynthia Brinson,2 Princy Kumar,3 Edwin DeJesus,4 Robert Ryan,5 Michelle Cho,6 David Anderson6
1Peter J Ruane MD Inc., Los Angeles, California, USA; 2Central Texas Clinical Research, Austin, Texas, USA; 3Georgetown University School of Medicine, Washington, DC, USA; 4Orlando Immunology Center, Orlando, Florida, USA; 5Janssen Research & Development, Titusville, New Jersey, USA; 6Janssen Services, LLC, Titusville, New Jersey, USA

IAS1.gif

IAS2.gif

IAS3.gif

IAS4.gif

IAS5.gif

IAS6.gif

IAS7.gif

IAS8.gif

IAS9.gif

IAS10.gif

IAS11.gif

IAS12.gif

IAS13.gif

IAS14.gif

IAS15.gif

IAS16.gif

IAS17.gif

IAS18.gif

IAS19.gif

IAS20.gif

IAS21.gif

IAS22.gif